申请人:——
公开号:US20040138268A1
公开(公告)日:2004-07-15
Novel aminoalkylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders responsive to the opening of the KCNQ potassium channels, including pain and migraine.
1
描述了一种公式I的新型
氨基烷基
噻唑衍
生物,它们是KCNQ
钾通道的开放剂,并可用于治疗对KCNQ
钾通道开放有反应的疾病,包括疼痛和偏头痛。